in this issue
Markets :: Specialty Chemicals :: Catalysts
Reaxa Secures U.K. Grant for Pharma Catalyst
10:12 AM MDT | July 21, 2010 | Laura Templer
The U.K.’s Technology Strategy Board, a U.K. government agency, has awarded £718,000 ($920,000) to a consortium led by catalyst firm Reaxa (Manchester, U.K.) to commercialize CP-STAR, a clean, low cost catalyst for processing pharmaceuticals. CP-STAR has been developed in collaboration between Reaxa and John Blacker, professor of chemistry at the University of Leeds (Leeds, U.K.). The benefits of CP-STAR are that it can remove processing and complex purification steps in the manufacture of drugs. The catalyst can lower precious metal and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee